AACR 2022: Stand Up to Cancer, Standing up to Treatment
At the AACR 2022 Annual Meeting, a session titled “Optimizing Cell-based Therapies for Clinical Impact,’ an open scientific session, was hosted by Raymond DuBois, the Dean of the College of Medicine at the Medical University of South Carolina. Researchers discussed advancements in optimizing cell-based therapies for various cancers. The theme of the research presented by the 4 groups was the increasing specificity with which therapies are able to target cancer cells and the current problems with broad solutions such as chemotherapy and radiation.
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02